Data / Form D filings / Yuva Biosciences, Inc.
Yuva Biosciences, Inc.: Form D filings
Yuva Biosciences, Inc., a company in Birmingham, AL, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on March 24, 2026, reports $1.1 million sold of a $3 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1500 1ST AVENUE N SUITE L 133, Birmingham, AL, 35203
- Phone
- (205) 250-8000
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1998258
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | New notice | $3,000,000 | $1,118,000 | $1,882,000 | 11 | Mar 16, 2026 | sec.gov |
| Nov 7, 2023 | New notice | $4,500,000 | $0 | $4,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Greg Schmergel | Executive Officer, Director | |
| Fred Ehrsam | Director | |
| Daniel Browne | Director |
Other companies in Alabama that filed recently
- Quad Marketplace, Co. $47,500 · Aug 6, 2026
Every Form D from the week of Mar 23, 2026 · All recent filings in Alabama · All recent Other filings
Read from SEC EDGAR. Amount sold is what Yuva Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.